No Data
Alkermes Shareholders Approve Board Changes and Stock Plan
Alkermes to Participate in Two Upcoming Investor Conferences
DUBLIN, May 29, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in fireside chat presentations at two upcoming investor conferences.Jefferies Healthca
Alkermes to Present Promising Narcolepsy Treatment Data at Annual Sleep Conference
Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024PRNewswire– Late-Breaking Abstracts Containing Data From the Full Narcolepsy Type 1 Cohort From the ALKS 2680 Phase 1b Study and Vibran
Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024
– Late-Breaking Abstracts Containing Data From the Full Narcolepsy Type 1 Cohort From the ALKS 2680 Phase 1b Study and Vibrance-1 Phase 2 Study Design Accepted for Poster Presentations –– Findings Fro
Will Weakness in Alkermes Plc's (NASDAQ:ALKS) Stock Prove Temporary Given Strong Fundamentals?
With its stock down 19% over the past three months, it is easy to disregard Alkermes (NASDAQ:ALKS). However, stock prices are usually driven by a company's financial performance over the long term,
6 Analysts Assess Alkermes: What You Need To Know
Alkermes (NASDAQ:ALKS) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The following table encapsulates their recent ratings